ANN ARBOR, Mich., Nov. 19, 2024 /PRNewswire/ — Ambient Biosciences, a pioneering life science company, today announced the launch of its Early Access Program (EAP), seeking partners to trial their technology. This innovative program offers partners the opportunity to experience the transformative power of ambient biomolecule stabilization firsthand in their own laboratories. This program is ideal for organizations looking to elevate their science or supply chain by stably processing biological materials, reducing cold storage dependence, cutting shipping costs, and significantly extending product shelf lives.

By partnering with leading institutions like Cayman Chemical, Ambient Biosciences aims to accelerate the adoption of this groundbreaking technology and reshape the future of biomolecule storage and distribution.

Read the full article on prnewswire.com